You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

talazoparib

Showing 51 - 71 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced or Metastatic Solid Tumors, Genes, BRCA 1 Trial in Worldwide (Avelumab, Talazoparib)

Active, not recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • Genes, BRCA 1
  • Palo Alto, California
  • +89 more
Jan 18, 2023

Advanced Solid Tumors Trial in Canada, United States (Talazoparib)

Completed
Has Results
  • Advanced Solid Tumors
  • Talazoparib
  • Fort Wayne, Indiana
  • +9 more
Dec 11, 2020

Advanced Malignant Pleural or Peritoneal Mesothelioma Trial (Talazoparib)

Not yet recruiting
  • Advanced Malignant Pleural or Peritoneal Mesothelioma
  • Talazoparib
  • (no location specified)
Jul 8, 2020

Endometrial Cancer Trial in United States (Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib)

Recruiting
  • Endometrial Cancer
  • Atezolizumab - 28 Day Cycle
  • +6 more
  • Duarte, California
  • +13 more
Jun 8, 2022

Adult Solid Tumor, Childhood Solid Tumor, Recurrent Childhood CNS Tumor Trial in United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • Adult Solid Neoplasm
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +21 more
Mar 1, 2021

Early Breast Cancer Trial in United States (TALAZOPARIB)

Terminated
Has Results
  • Early Breast Cancer
  • TALAZOPARIB
  • Gilbert, Arizona
  • +96 more
Oct 11, 2021

Extensive Stage Lung Small Cell Carcinoma Trial in United States (Atezolizumab, Talazoparib)

Active, not recruiting
  • Extensive Stage Lung Small Cell Carcinoma
  • Anchorage, Alaska
  • +564 more
Jan 28, 2023

Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib, Physician's-Choice)

Completed
Has Results
  • Breast Neoplasms
  • +2 more
  • Flagstaff, Arizona
  • +361 more
Dec 20, 2021

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer

Active, not recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +4 more
  • Mobile, Alabama
  • +324 more
Sep 21, 2021

Solid Tumor Trial in United States (Talazoparib)

Completed
Has Results
  • Solid Tumor
  • Talazoparib
  • Bakersfield, California
  • +18 more
Dec 13, 2019

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

ATM Gene Mutation, ATR Gene Mutation, BARD1 Gene Mutation Trial in Canada, United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • ATM Gene Mutation
  • +20 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +1156 more
Jun 22, 2021

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Birmingham, Alabama
  • +125 more
Nov 21, 2022

Advanced Solid Tumors Trial in Budapest (Talazoparib)

Completed
Has Results
  • Advanced Solid Tumors
  • Talazoparib
  • Budapest, Hungary
    PRA Magyarorszag Kft, Fazis I-es Klinikai Farmakologiai Vizsgalo
May 25, 2018

Ovarian Cancer Trial (Talazoparib, Temozolomide)

Withdrawn
  • Ovarian Cancer
  • (no location specified)
Sep 14, 2018

Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)

Terminated
Has Results
  • Breast Neoplasms
  • +2 more
  • talazoparib
  • Greenbrae, California
  • +70 more
Oct 10, 2019

Treating Recurrent Stage IV Squamous Cell Lung Cancer

Active, not recruiting
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Birmingham, Alabama
  • +1003 more
Nov 29, 2021

Estrogen Receptor Negative, Head and Neck Squamous Cell Carcinoma, HER2/Neu Negative Trial (Laboratory Biomarker Analysis,

Withdrawn
  • Estrogen Receptor Negative
  • +22 more
  • Laboratory Biomarker Analysis
  • +2 more
  • (no location specified)
Apr 20, 2017

Adult Solid Tumor, Estrogen Receptor Negative, Fallopian Tube Serous Tumor Trial (Hsp90 Inhibitor AT13387, Laboratory Biomarker

Withdrawn
  • Adult Solid Neoplasm
  • +12 more
  • Hsp90 Inhibitor AT13387
  • +3 more
  • (no location specified)
Jul 22, 2016

Solid Tumors, Carcinoma, Non-Small Cell Lung, NSCLC Trial (Cisplatin, Gemcitabine, Talazoparib)

Withdrawn
  • Solid Tumors
  • +4 more
  • (no location specified)
Feb 10, 2016